Maynard Um
-
-
-
-
-
-
-
Passage Bio reports interim trial data, initiates strategic review
-
-
-
-
-
-
-
Passage Bio (PASG) Reports Updated Interim Data from upliFT-D Study and Provides Program Update
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Buy Rating on Passage Bio Inc. (PASG)
-
-
-
-
397,093 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

